位置:首页 > 蛋白库 > CDS2_MOUSE
CDS2_MOUSE
ID   CDS2_MOUSE              Reviewed;         444 AA.
AC   Q99L43; Q3TMD1; Q6NSU1;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   03-AUG-2022, entry version 153.
DE   RecName: Full=Phosphatidate cytidylyltransferase 2 {ECO:0000305};
DE            EC=2.7.7.41 {ECO:0000250|UniProtKB:O95674};
DE   AltName: Full=CDP-DAG synthase 2;
DE   AltName: Full=CDP-DG synthase 2;
DE   AltName: Full=CDP-diacylglycerol synthase 2;
DE            Short=CDS 2;
DE   AltName: Full=CDP-diglyceride pyrophosphorylase 2;
DE   AltName: Full=CDP-diglyceride synthase 2;
DE   AltName: Full=CTP:phosphatidate cytidylyltransferase 2;
GN   Name=Cds2 {ECO:0000312|MGI:MGI:1332236};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=C57BL/6J;
RX   PubMed=16023307; DOI=10.1016/j.gene.2005.04.037;
RA   Inglis-Broadgate S.L., Ocaka L., Banerjee R., Gaasenbeek M., Chapple J.P.,
RA   Cheetham M.E., Clark B.J., Hunt D.M., Halford S.;
RT   "Isolation and characterization of murine Cds (CDP-diacylglycerol synthase)
RT   1 and 2.";
RL   Gene 356:19-31(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Cerebellum, Embryonic stem cell, and Lung;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Embryo, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17208939; DOI=10.1074/mcp.m600218-mcp200;
RA   Lee J., Xu Y., Chen Y., Sprung R., Kim S.C., Xie S., Zhao Y.;
RT   "Mitochondrial phosphoproteome revealed by an improved IMAC method and
RT   MS/MS/MS.";
RL   Mol. Cell. Proteomics 6:669-676(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18630941; DOI=10.1021/pr800223m;
RA   Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.;
RT   "Specific phosphopeptide enrichment with immobilized titanium ion affinity
RT   chromatography adsorbent for phosphoproteome analysis.";
RL   J. Proteome Res. 7:3957-3967(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32; SER-36 AND THR-50, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [9]
RP   FUNCTION.
RX   PubMed=26946540; DOI=10.1194/jlr.m060574;
RA   Qi Y., Kapterian T.S., Du X., Ma Q., Fei W., Zhang Y., Huang X.,
RA   Dawes I.W., Yang H.;
RT   "CDP-diacylglycerol synthases regulate the growth of lipid droplets and
RT   adipocyte development.";
RL   J. Lipid Res. 57:767-780(2016).
CC   -!- FUNCTION: Catalyzes the conversion of phosphatidic acid (PA) to CDP-
CC       diacylglycerol (CDP-DAG), an essential intermediate in the synthesis of
CC       phosphatidylglycerol, cardiolipin and phosphatidylinositol (By
CC       similarity). Exhibits specificity for the nature of the acyl chains at
CC       the sn-1 and sn-2 positions in the substrate, PA and the preferred acyl
CC       chain composition is 1-stearoyl-2-arachidonoyl-sn-phosphatidic acid (By
CC       similarity). Plays an important role in regulating the growth and
CC       maturation of lipid droplets which are storage organelles at the center
CC       of lipid and energy homeostasis (PubMed:26946540).
CC       {ECO:0000250|UniProtKB:O95674, ECO:0000269|PubMed:26946540}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphate + CTP + H(+) = a CDP-1,2-
CC         diacyl-sn-glycerol + diphosphate; Xref=Rhea:RHEA:16229,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37563,
CC         ChEBI:CHEBI:58332, ChEBI:CHEBI:58608; EC=2.7.7.41;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16230;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphate + CTP + H(+) = 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-
CC         eicosatetraenoyl)-sn-glycero-3-cytidine-5'-diphosphate + diphosphate;
CC         Xref=Rhea:RHEA:45648, ChEBI:CHEBI:15378, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:37563, ChEBI:CHEBI:77091, ChEBI:CHEBI:85349;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45649;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-
CC         phosphate + CTP + H(+) = 1-octadecanoyl-2-(9Z,12Z-octadecadienoyl)-
CC         sn-glycero-3-cytidine-5'-diphosphate + diphosphate;
CC         Xref=Rhea:RHEA:45660, ChEBI:CHEBI:15378, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:37563, ChEBI:CHEBI:77098, ChEBI:CHEBI:85352;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45661;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphate + CTP + H(+) = 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-
CC         eicosatetraenoyl)-sn-glycero-3-cytidine-5'-diphosphate + diphosphate;
CC         Xref=Rhea:RHEA:45652, ChEBI:CHEBI:15378, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:37563, ChEBI:CHEBI:72864, ChEBI:CHEBI:85350;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45653;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphate
CC         + CTP + H(+) = 1,2-di-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-
CC         cytidine-5'-diphosphate + diphosphate; Xref=Rhea:RHEA:45656,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37563,
CC         ChEBI:CHEBI:77126, ChEBI:CHEBI:85351;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45657;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate +
CC         CTP + H(+) = 1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         cytidine-5'-diphosphate + diphosphate; Xref=Rhea:RHEA:45664,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37563,
CC         ChEBI:CHEBI:74560, ChEBI:CHEBI:85353;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45665;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-
CC         glycero-3-phosphate + CTP + H(+) = 1-octadecanoyl-2-
CC         (4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-cytidine-5'-
CC         diphosphate + diphosphate; Xref=Rhea:RHEA:45668, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:37563, ChEBI:CHEBI:77130,
CC         ChEBI:CHEBI:85354; Evidence={ECO:0000250|UniProtKB:O95674};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45669;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate + CTP +
CC         H(+) = 1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-cytidine-5'-
CC         diphosphate + diphosphate; Xref=Rhea:RHEA:45672, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:37563, ChEBI:CHEBI:77128,
CC         ChEBI:CHEBI:85355; Evidence={ECO:0000250|UniProtKB:O95674};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45673;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CTP + H(+) =
CC         1,2-di-(9Z-octadecenoyl)-sn-glycero-3-cytidine-5'-diphosphate +
CC         diphosphate; Xref=Rhea:RHEA:45676, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:37563, ChEBI:CHEBI:74546,
CC         ChEBI:CHEBI:85356; Evidence={ECO:0000250|UniProtKB:O95674};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45677;
CC         Evidence={ECO:0000250|UniProtKB:O95674};
CC   -!- PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-
CC       diacylglycerol from sn-glycerol 3-phosphate: step 3/3.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:Q91XU8}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:16023307}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Expressed in the ganglion cell layer
CC       and inner nuclear layer of the retina. {ECO:0000269|PubMed:16023307}.
CC   -!- SIMILARITY: Belongs to the CDS family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY159802; AAO17790.1; -; mRNA.
DR   EMBL; AK036328; BAC29384.1; -; mRNA.
DR   EMBL; AK147541; BAE27984.1; -; mRNA.
DR   EMBL; AK166001; BAE38511.1; -; mRNA.
DR   EMBL; BC003852; AAH03852.1; -; mRNA.
DR   EMBL; BC069879; AAH69879.1; -; mRNA.
DR   CCDS; CCDS16772.1; -.
DR   RefSeq; NP_001277968.1; NM_001291039.1.
DR   RefSeq; NP_619592.1; NM_138651.7.
DR   AlphaFoldDB; Q99L43; -.
DR   BioGRID; 226008; 9.
DR   IntAct; Q99L43; 1.
DR   MINT; Q99L43; -.
DR   STRING; 10090.ENSMUSP00000099470; -.
DR   GlyConnect; 2581; 1 N-Linked glycan (1 site).
DR   GlyGen; Q99L43; 1 site, 1 N-linked glycan (1 site).
DR   iPTMnet; Q99L43; -.
DR   PhosphoSitePlus; Q99L43; -.
DR   SwissPalm; Q99L43; -.
DR   EPD; Q99L43; -.
DR   jPOST; Q99L43; -.
DR   MaxQB; Q99L43; -.
DR   PaxDb; Q99L43; -.
DR   PeptideAtlas; Q99L43; -.
DR   PRIDE; Q99L43; -.
DR   ProteomicsDB; 281301; -.
DR   Antibodypedia; 8142; 151 antibodies from 23 providers.
DR   DNASU; 110911; -.
DR   Ensembl; ENSMUST00000103181; ENSMUSP00000099470; ENSMUSG00000058793.
DR   GeneID; 110911; -.
DR   KEGG; mmu:110911; -.
DR   UCSC; uc008mmo.2; mouse.
DR   CTD; 8760; -.
DR   MGI; MGI:1332236; Cds2.
DR   VEuPathDB; HostDB:ENSMUSG00000058793; -.
DR   eggNOG; KOG1440; Eukaryota.
DR   GeneTree; ENSGT00940000158877; -.
DR   InParanoid; Q99L43; -.
DR   OMA; REVAIMP; -.
DR   OrthoDB; 1072976at2759; -.
DR   PhylomeDB; Q99L43; -.
DR   TreeFam; TF313464; -.
DR   BRENDA; 2.7.7.41; 3474.
DR   Reactome; R-MMU-1483148; Synthesis of PG.
DR   UniPathway; UPA00557; UER00614.
DR   BioGRID-ORCS; 110911; 26 hits in 77 CRISPR screens.
DR   ChiTaRS; Cds2; mouse.
DR   PRO; PR:Q99L43; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q99L43; protein.
DR   Bgee; ENSMUSG00000058793; Expressed in motor neuron and 255 other tissues.
DR   ExpressionAtlas; Q99L43; baseline and differential.
DR   Genevisible; Q99L43; MM.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0004605; F:phosphatidate cytidylyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0016024; P:CDP-diacylglycerol biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0070085; P:glycosylation; NAS:BHF-UCL.
DR   GO; GO:0140042; P:lipid droplet formation; IMP:UniProtKB.
DR   GO; GO:0007602; P:phototransduction; TAS:BHF-UCL.
DR   InterPro; IPR000374; PC_trans.
DR   InterPro; IPR016720; PC_Trfase_euk.
DR   PANTHER; PTHR13773; PTHR13773; 1.
DR   PIRSF; PIRSF018269; PC_trans_euk; 1.
DR   PROSITE; PS01315; CDS; 1.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Nucleotidyltransferase; Phospholipid biosynthesis; Phospholipid metabolism;
KW   Phosphoprotein; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..444
FT                   /note="Phosphatidate cytidylyltransferase 2"
FT                   /id="PRO_0000090717"
FT   TRANSMEM        78..98
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        129..149
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        165..185
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        212..232
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        261..281
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        339..359
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          1..48
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..34
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         20
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95674"
FT   MOD_RES         30
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O95674"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17208939,
FT                   ECO:0007744|PubMed:17242355, ECO:0007744|PubMed:18630941,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         34
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95674"
FT   MOD_RES         36
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         50
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   CONFLICT        43
FT                   /note="L -> P (in Ref. 3; AAH69879)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   444 AA;  51314 MW;  6A3568A7E90A6C53 CRC64;
     MTELRQRVVR EDAPPEDKES ESEAKLDGET ASDSESRAET APLPTSVDDT PEVLNRALSN
     LSSRWKNWWV RGILTLAMIA FFFIIIYLGP MVLMMIVMCV QIKCFHEIIT IGYNVYHSYD
     LPWFRTLSWY FLLCVNYFFY GETVTDYFFT LVQREEPLRI LSKYHRFISF ALYLTGFCMF
     VLSLVKKHYR LQFYMFGWTH VTLLIVVTQS HLVIHNLFEG MIWFIVPISC VICNDIMAYM
     FGFFFGRTPL IKLSPKKTWE GFIGGFFATV VFGLLLSYVM SGYRCFVCPV EYNNDTNSFT
     VDCEPSDLFR LQEYNIPGVI QSAIGWKTVR MYPFQIHSIA LSTFASLIGP FGGFFASGFK
     RAFKIKDFAN TIPGHGGIMD RFDCQYLMAT FVNVYIASFI RGPNPSKLIQ QFLTLRPDQQ
     LHIFNTLKSH LTDKGILTSA LEDE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024